United States Pharmaceuticals

Processa Pharmaceuticals Inc (PCSA)

Track

Over the past 90 days, Processa Pharmaceuticals Inc. saw significant insider activity, with six executives executing 26 buy transactions totaling approximately $130,096.50. There were no reported sales during this period. These purchases occurred ahead of the next earnings report scheduled for August 6, 2026, following a 13% stock price increase over the last quarter.
Ticker: PCSA Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Processa Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 1 Jul 2026
Value US$1,803,024.71 | Price 88.45 | Shares 73,513 (-46.7%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-01 2026-07-01 B Purchase
1.3
Ng George K

Chief Executive Officer

Executive Director
73,513 -46.7%
88.45
US$1,803,025 		73,513 -46.7% 88.45 US$1,803,025
2026-07-01 2026-06-30 B Purchase
2.9
Lin Patrick

Chief Business - Strategy Off

Officer
84,043 +26.6%
257.80
US$2,583,648 		84,043 +26.6% 257.80 US$2,583,648
2026-07-01 2026-06-30 B Purchase
Guy Wendy

Chief Administrative Officer

Officer
33,280 -17.5%
382.36
US$4,584,906 		33,280 -17.5% 382.36 US$4,584,906
2026-07-01 2026-06-30 B Purchase
SKIBSTED RUSSELL

Chief Financial Officer

Officer
3,277 +24.4%
1.93
US$6,325 		3,277 +24.4% 1.93 US$6,325
2026-07-01 2026-06-30 B Purchase
2.1
Young David

Pres. Research & Development

Executive Director
2,531 +13.2%
1.93
US$4,885 		2,531 +13.2% 1.93 US$4,885
2026-06-16 2026-06-15 B Purchase
2.1
Young David

Pres. Research & Development

Executive Director
2,067 +12.1%
2.22
US$4,589 		2,067 +12.1% 2.22 US$4,589
2026-06-16 2026-06-15 B Purchase
SKIBSTED RUSSELL

Chief Financial Officer

Officer
2,654 +24.7%
2.22
US$5,892 		2,654 +24.7% 2.22 US$5,892
2026-06-16 2026-06-15 B Purchase
1.3
Ng George K

Chief Executive Officer

Executive Director
2,465 +24.7%
2.22
US$5,472 		2,465 +24.7% 2.22 US$5,472
2026-06-16 2026-06-15 B Purchase
2.9
Lin Patrick

Chief Business - Strategy Off

Officer
1,831 +20.0%
2.22
US$4,065 		1,831 +20.0% 2.22 US$4,065
2026-06-16 2026-06-15 B Purchase
Guy Wendy

Chief Administrative Officer

Officer
2,118 +21.5%
2.22
US$4,702 		2,118 +21.5% 2.22 US$4,702
2026-06-01 2026-05-29 B Purchase
2.1
Young David

Pres. Research & Development

Executive Director
1,786 +11.6%
2.57
US$4,590 		1,786 +11.6% 2.57 US$4,590
2026-06-01 2026-05-29 B Purchase
SKIBSTED RUSSELL

Chief Financial Officer

Officer
2,292 +27.1%
2.57
US$5,890 		2,292 +27.1% 2.57 US$5,890
2026-06-01 2026-05-29 B Purchase
Guy Wendy

Chief Administrative Officer

Officer
1,829 +22.8%
2.57
US$4,701 		1,829 +22.8% 2.57 US$4,701
2026-06-01 2026-05-29 B Purchase
1.3
Ng George K

Chief Executive Officer

Executive Director
2,129 +27.2%
2.57
US$5,472 		2,129 +27.2% 2.57 US$5,472
2026-06-01 2026-05-29 B Purchase
2.9
Lin Patrick

Chief Business - Strategy Off

Officer
1,582 +20.8%
2.57
US$4,066 		1,582 +20.8% 2.57 US$4,066
2026-05-19 2026-05-15 B Purchase
2.9
Lin Patrick

Chief Business - Strategy Off

Officer
1,369 +22.0%
2.97
US$4,066 		1,369 +22.0% 2.97 US$4,066
2026-05-19 2026-05-15 B Purchase
SKIBSTED RUSSELL

Chief Financial Officer

Officer
1,984 +30.6%
2.97
US$5,892 		1,984 +30.6% 2.97 US$5,892
2026-05-19 2026-05-15 B Purchase
Guy Wendy

Chief Administrative Officer

Officer
1,583 +24.6%
2.97
US$4,702 		1,583 +24.6% 2.97 US$4,702
2026-05-19 2026-05-15 B Purchase
1.3
Ng George K

Chief Executive Officer

Executive Director
1,843 +30.7%
2.97
US$5,474 		1,843 +30.7% 2.97 US$5,474
2026-05-19 2026-05-15 B Purchase
2.1
Young David

Pres. Research & Development

Executive Director
1,545 +11.2%
2.97
US$4,589 		1,545 +11.2% 2.97 US$4,589
2026-05-01 2026-04-30 B Purchase
1.3
Ng George K

Chief Executive Officer

Executive Director
2,034 +51.1%
2.69
US$5,471 		2,034 +51.1% 2.69 US$5,471
2026-05-01 2026-04-30 B Purchase
2.1
Young David

Pres. Research & Development

Executive Director
1,706 +14.1%
2.69
US$4,589 		1,706 +14.1% 2.69 US$4,589
2026-05-01 2026-04-30 B Purchase
2.9
Lin Patrick

Chief Business - Strategy Off

Officer
1,511 +32.0%
2.69
US$4,065 		1,511 +32.0% 2.69 US$4,065
2026-05-01 2026-04-30 B Purchase
SKIBSTED RUSSELL

Chief Financial Officer

Officer
2,190 +50.8%
2.69
US$5,891 		2,190 +50.8% 2.69 US$5,891
2026-05-01 2026-04-30 B Purchase
Bigora Sian

Chief Development Officer

Officer
1,986 +36.0%
2.69
US$5,342 		1,986 +36.0% 2.69 US$5,342
2026-05-01 2026-04-30 B Purchase
Guy Wendy

Chief Administrative Officer

Officer
1,748 +37.2%
2.69
US$4,702 		1,748 +37.2% 2.69 US$4,702
2026-04-17 2026-04-15 B Purchase
1.3
Ng George K

Chief Executive Officer

Executive Director
1,843 +50.5%
2.97
US$5,474 		1,843 +50.5% 2.97 US$5,474
2026-04-17 2026-04-15 B Purchase
2.1
Young David

Pres. Research & Development

Executive Director
1,545 +14.6%
2.97
US$4,589 		1,545 +14.6% 2.97 US$4,589
2026-04-17 2026-04-15 B Purchase
2.9
Lin Patrick

Chief Business - Strategy Off

Officer
1,369 +40.8%
2.97
US$4,066 		1,369 +40.8% 2.97 US$4,066
2026-04-17 2026-04-15 B Purchase
Guy Wendy

Chief Administrative Officer

Officer
1,583 +50.9%
2.97
US$4,702 		1,583 +50.9% 2.97 US$4,702
2026-04-17 2026-04-15 B Purchase
Bigora Sian

Chief Development Officer

Officer
1,799 +48.5%
2.97
US$5,343 		1,799 +48.5% 2.97 US$5,343
2026-04-17 2026-04-15 B Purchase
SKIBSTED RUSSELL

Chief Financial Officer

Officer
1,984 +85.4%
2.97
US$5,892 		1,984 +85.4% 2.97 US$5,892
2026-04-02 2026-03-31 B Purchase
3.8
Neal James R
Non-Executive Director
789 +2720.7%
2.54
US$2,000 		789 +2720.7% 2.54 US$2,000
2026-04-01 2026-03-31 B Purchase
Pannu Geraldine
Non-Executive Director
2,072 +1786.2%
2.54
US$5,253 		2,072 +1786.2% 2.54 US$5,253
2026-04-01 2026-03-31 B Purchase
2.1
Young David

Pres. Research & Development

Executive Director
1,810 +20.7%
2.54
US$4,588 		1,810 +20.7% 2.54 US$4,588
2026-04-01 2026-03-31 B Purchase
Bigora Sian

Chief Development Officer

Officer
2,107 +131.4%
2.54
US$5,341 		2,107 +131.4% 2.54 US$5,341
2026-04-01 2026-03-31 B Purchase
Guy Wendy

Chief Administrative Officer

Officer
1,854 +147.6%
2.54
US$4,700 		1,854 +147.6% 2.54 US$4,700
2026-04-01 2026-03-31 B Purchase
1.3
Ng George K

Chief Executive Officer

Executive Director
2,136 +141.2%
2.54
US$5,415 		2,136 +141.2% 2.54 US$5,415
2026-04-01 2026-03-31 B Purchase
SKIBSTED RUSSELL

Chief Financial Officer

Officer
2,324 +inf%
2.54
US$5,891 		2,324 +inf% 2.54 US$5,891
2026-04-01 2026-03-31 B Purchase
2.9
Lin Patrick

Chief Business - Strategy Off

Officer
1,603 +91.4%
2.54
US$4,064 		1,603 +91.4% 2.54 US$4,064
2026-04-01 2026-03-31 B Purchase
2.2
Baluch Khoso
Non-Executive Director
2,269 +4051.8%
2.54
US$5,752 		2,269 +4051.8% 2.54 US$5,752
2025-01-31 2025-01-27 B Purchase
2.6
Yorke Justin W
Non-Executive Director
12,400 +inf%
0.80
US$9,889 		12,400 +inf% 0.80 US$9,889
2025-01-29 2025-01-27 B Purchase
1.3
Ng George K

Chief Executive Officer

Executive Director
87,200 +inf%
0.80
US$69,542 		87,200 +inf% 0.80 US$69,542
2025-01-29 2025-01-27 B Purchase
2.1
Young David

Pres. Research & Development

Executive Director
124,500 +153.9%
0.80
US$99,289 		124,500 +153.9% 0.80 US$99,289
2025-01-29 2025-01-27 B Purchase
2.9
Lin Patrick

Chief Business - Strategy Off

Officer
43,500 +inf%
0.80
US$34,691 		43,500 +inf% 0.80 US$34,691
2024-02-08 2024-02-07 B Purchase
2.1
Young David

Pres. Research & Development

Executive Director
21,000 +36.0%
2.45
US$51,526 		21,000 +36.0% 2.45 US$51,526
2024-02-07 2024-02-06 B Purchase
2.1
Young David

Pres. Research & Development

Executive Director
20,000 +52.1%
2.53
US$50,504 		20,000 +52.1% 2.53 US$50,504
2024-02-01 2024-02-01 B Purchase
2.9
Lin Patrick

Chief Business - Strategy Off

Officer
1,500 +5.8%
2.40
US$3,600 		1,500 +5.8% 2.40 US$3,600
2024-02-01 2024-01-31 B Purchase
2.9
Lin Patrick

Chief Business - Strategy Off

Officer
2,500 +10.6%
2.37
US$5,925 		2,500 +10.6% 2.37 US$5,925
2024-01-31 2024-01-30 B Purchase
1.3
Ng George K

Chief Executive Officer

Executive Director
10,000 +100.0%
2.70
US$27,000 		10,000 +100.0% 2.70 US$27,000
2024-01-31 2024-01-30 B Purchase
2.6
Yorke Justin W
Non-Executive Director
8,000 +34.4%
2.69
US$21,544 		8,000 +34.4% 2.69 US$21,544
2023-06-12 2023-06-12 B Purchase
2.1
Young David

President & CEO

Executive Director Large shareholder
40,000 +9.3%
0.80
US$32,000 		40,000 +9.3% 0.80 US$32,000
2023-04-14 2023-04-14 B Purchase
2.1
Young David

President & CEO

Executive Director Large shareholder
20,000 +4.9%
0.55
US$10,998 		20,000 +4.9% 0.55 US$10,998
2023-04-13 2023-04-13 B Purchase
2.1
Young David

President & CEO

Executive Director Large shareholder
20,000 +5.1%
0.48
US$9,600 		20,000 +5.1% 0.48 US$9,600
2023-04-13 2023-04-12 B Purchase
2.1
Young David

President & CEO

Executive Director Large shareholder
20,000 +5.4%
0.45
US$9,000 		20,000 +5.4% 0.45 US$9,000
2023-04-13 2023-04-11 B Purchase
2.1
Young David

President & CEO

Executive Director Large shareholder
20,000 +5.7%
0.52
US$10,400 		20,000 +5.7% 0.52 US$10,400
2022-05-19 2022-05-17 B Purchase
2.9
Lin Patrick

Chief Business - Strategy Off

Officer
2,000 +0.5%
1.59
US$3,189 		2,000 +0.5% 1.59 US$3,189
2022-04-08 2022-04-07 B Purchase
2.9
Lin Patrick

Chief Business - Strategy Off

Officer
800 +0.2%
3.54
US$2,835 		800 +0.2% 3.54 US$2,835
2022-04-08 2022-04-06 B Purchase
2.9
Lin Patrick

Chief Business - Strategy Off

Officer
1,200 +0.3%
3.13
US$3,752 		1,200 +0.3% 3.13 US$3,752
2022-01-31 2022-01-27 S Sale
2.6
Yorke Justin W
Non-Executive Director
1,854 -0.3%
3.30
US$6,118 		1,854 -0.3% 3.30 US$6,118
2022-01-04 2021-12-14 B Purchase
2.9
Lin Patrick

Chief Business - Strategy Off

Officer
3,000 +0.7%
4.00
US$12,000 		3,000 +0.7% 4.00 US$12,000
2021-12-16 2021-12-14 B Purchase
2.9
Lin Patrick

Chief Business - Strategy Off

Officer
3,000 +0.7%
4.00
US$12,000 		3,000 +0.7% 4.00 US$12,000
2021-12-07 2021-12-06 S Sale
2.6
Yorke Justin W
Non-Executive Director
4,200 -0.8%
4.71
US$19,784 		4,200 -0.8% 4.71 US$19,784
2021-12-07 2021-12-03 B Purchase
2.9
Lin Patrick

Chief Business - Strategy Off

Officer
3,500 +0.8%
4.80
US$16,795 		3,500 +0.8% 4.80 US$16,795
2021-12-07 2021-12-03 S Sale
2.6
Yorke Justin W
Non-Executive Director
5,500 -1.0%
4.84
US$26,599 		5,500 -1.0% 4.84 US$26,599
2021-06-23 2021-06-23 B Purchase
2.1
Young David

Chief Executive Officer

Executive Director Large shareholder
10,000 +3.0%
7.67
US$76,716 		10,000 +3.0% 7.67 US$76,716
2021-06-22 2021-06-22 B Purchase
1.7
Floyd Robert Michael

Chief Operating Officer

Officer
2,000 +7.7%
7.03
US$14,058 		2,000 +7.7% 7.03 US$14,058
2021-06-22 2021-06-21 B Purchase
2.9
Lin Patrick

Chief Business - Strategy Off

Officer
2,000 +0.5%
6.65
US$13,300 		2,000 +0.5% 6.65 US$13,300
2021-04-08 2021-04-08 S Sale
4.0
BESSER JAMES E
400,000 -38.2%
10.76
US$4,304,000 		400,000 -38.2% 10.76 US$4,304,000
2021-04-08 2021-04-07 S Sale
4.0
BESSER JAMES E
16,000 -1.5%
10.67
US$170,720 		16,000 -1.5% 10.67 US$170,720
2021-04-08 2021-04-06 S Sale
4.0
BESSER JAMES E
31,771 -2.9%
10.91
US$346,622 		31,771 -2.9% 10.91 US$346,622
2021-02-22 2021-02-22 S Sale
4.0
BESSER JAMES E
Large shareholder
20,929 -1.9%
11.56
US$241,939 		20,929 -1.9% 11.56 US$241,939
2021-02-22 2021-02-19 S Sale
4.0
BESSER JAMES E
Large shareholder
3,000 -0.3%
11.20
US$33,600 		3,000 -0.3% 11.20 US$33,600
2021-02-22 2021-02-18 S Sale
4.0
BESSER JAMES E
Large shareholder
5,000 -0.4%
11.35
US$56,750 		5,000 -0.4% 11.35 US$56,750
2020-10-13 2020-10-02 B Purchase
4.0
BESSER JAMES E
Large shareholder
30,000 +8.0%
4.04
US$121,200 		30,000 +8.0% 4.04 US$121,200
Explore more

More insider trading research around Processa Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America